glp-1 cigna coverage is making a harder sell for employers Rebates Drive U.S. Payer Coverage

The combination of lawsuits over compounded drugs and an FDA warning on Wegovy advertising could influence how Novo Nordisk markets its products and protects its patents

In the SELECT trial, patients did not enroll for the specific purpose of weight loss and received standard of care covering management of CV risk factors, including medical treatment and healthy lifestyle counseling, but without a specific focus on weight loss

Louisiana Patients Could Lose Access to GLP-1 Weight-Loss Drugs as Coverage Vanishes Highlights Louisiana state employees are already prohibited from using GLP-1s for weight loss despite $200 million annual spending on diabetes coverage Over 41 million Americans lost commercial insurance coverage for Wegovy in 2026, with major insurers eliminating coverage nationwide Four states, including California and Pennsylvania, eliminated Medicaid coverage for obesity treatment between October 2025 and January 2026 Louisiana Medicaid provides limited coverage for one non-GLP-1 weight-loss drug but restrictions remain tight Patients face monthly costs ranging from $936 to $1,349 without insurance coverage BATON ROUGE, La

Does your Medicare Part D plan already cover a GLP-1 medication for another approved condition

However, practical considerations exist regarding gastrointestinal tolerability

Dynamic PET scans over 60 minutes showed a high pancreatic uptake of a bicyclic GLP-1 analog, [D-Ala 8 ]-c[Glu 18 ,Lys 22 ]-c[Glu 30 ,Lys 34 ]-GLP-1 736 , labeled with 64 Cu or 68 Ga, which disappeared in streptozotocin-induced type 1 diabetic mice or was competitively displaced by coinjection of unlabeled exendin-4 (Manandhar et al., 2013)